Aducanumab (Aduhelm), a treatment for Alzheimer's disease, will be discontinued by its manufacturer (Biogen) in 2024.
People also ask
Is Aduhelm approved in Canada?
Why is Aduhelm being discontinued?
How successful is Aduhelm?
How expensive is Aduhelm?
Aducanumab, also known by its brand name Aduhelm, was a drug designed for early Alzheimer's disease that received a lot of global media coverage in 2021 and ...
Jul 8, 2021 · Aduhelm is an amyloid beta-directed antibody indicated for the treatment of Alzheimer's disease.
ADUHELM is the first treatment to reduce amyloid plaques in the brains of people with Alzheimer's disease. See Safety and Prescribing info.
Aducanumab
Medication
Aducanumab, sold under the brand name Aduhelm, is a medication designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms of amyloid beta found in the brains of people with Alzheimer's disease to reduce its... Wikipedia
Routes of administration: Intravenous
Source: Human
Other names: Aducanumab-avwa, BIIB037, BIIB-037
Target: Amyloid beta
ATC code: N06DX03 (WHO)
Elimination half-life: 24.8 days
License data: US DailyMed: Aducanumab
Oct 24, 2023 · Aducanumab (Aduhelm) is a drug for early Alzheimer's disease and mild cognitive impairment. Learn more about how it works.
Aducanumab, sold under the brand name Aduhelm, is a medication designed to treat Alzheimer's disease (AD). It is a monoclonal antibody that targets ...
Jan 31, 2024 · Company to reprioritize resources allocated to ADUHELM® (aducanumab-avwa) to advance LEQEMBI® (lecanemab-irmb) and to develop new treatment ...
Jan 31, 2024 · The Alzheimer's medication Aduhelm is being discontinued by drugmaker Biogen as it shifts resources to its other Alzheimer's medication, ...
Jun 6, 2022 · The FDA recently approved aducanumab (Aduhelm) for people with mild symptoms of Alzheimer disease, such as individuals who are still independent ...
How does Aduhelm work? The active substance in Aduhelm, aducanumab, is a monoclonal antibody (a type of protein) that attaches to a substance called amyloid ...